F. Gamarra (Munich, Germany), N. Triller (Golnik, Slovenia)
Phase I trial of pemetrexed, carboplatin and sorafenib as first-line treatment in patients with metastatic NSCLC
C. Brandts, B. Borchards, C. Waller, A. Kerkhoff, M. Mohr, C. Young, W. Berdel, R. Wiewrodt (Münster, Freiburg, Germany)
|  |
Efficacy and safety of Pemetrexed (PEM) for elderly patients with advanced non-small cell lung cancer (NSCLC) who had previous chemotherapy
N. Asai, Y. Ohkuni, R. Matsunuma, K. Nakashima, K. Ando, T. Iwasaki, D. Yasui, M. Misawa, N. Kaneko (Kamogawa, Japan)
| |
Combination therapy of gefitinib and CYP3A4 inhibitor on non-small-cell lung cancer patients with an EGFR mutation and carcinomatous meningitis
S. Okinaga, T. Suzuki, T. Tanaka, H. Miyazawa, K. Hagiwara (Moroyama, Japan)
| |
Concurrent chemoradiotherapy with carboplatin and paclitaxel followed by consolidation chemotherapy with vinorelbine for locally advanced inoperable nonsmall-cell lung cancer: A multiinstitutional phase II study
M. Izumi, K. Takayama, K. Tanaka, T. Matsumoto, K. Inoue, T. Oshima, M. Kawasaki, S. Tokunaga, Y. Nakanishi (Fukuoka, , Kitakyushu, Koga, Japan)
| |
Selective adjuvant chemotherapy according to in-vitro chemoresistance test: Long term follow up of patients with resectable non-small cell lung cancer (NSCLC) stage IIIA
V. Kolek, M. Hajduch, I. Grygarkova, J. Klein (Olomouc, Czech Republic)
| |
Efficacy and safety of amurubicin (AMR) for the elderly with refractory relapse small cell lung cancer (SCLC) who had previous treatment
N. Asai, Y. Ohkuni, R. Matsunuma, K. Nakashima, K. Ando, T. Iwasaki, D. Yasui, M. Misawa, N. Kaneko (Kamogawa, Japan)
| |
The correlation between clinical and pathomorphological impacts of induction chemotherapy and long-term results of multimodality treatment for IIIA stage non-small cell lung cancer
O. Sukhoversha, I. Bilen‘kiy, S. Chekan (Dnopropetrovs'k, Ukraine)
| |
Survival and respiratory effects in NSCLC patients after treatment with inhaled carboplatin
P. Zarogoulidis, T. Kontakiotis, V. Zarogoulidou, E. Eleftheriadou, I. Sapardanis, D. Gioulekas, K. Zarogoulidis (Exohi, Thessaloniki, Greece)
|  |
Mistletoe therapy for non-small cell bronchial carcinoma. Randomised open phase II study for the examination of the tolerance, safety and effectiveness of Viscum album extract in the palliative, additive treatment of advanced non-small cell bronchial carcinoma
C. Grah, B. Matthes, H. Happel (Berlin, Germany)
| |
Carboplatin and paclitaxel chemotherapy for lung cancer patients with interstitial lung disease
S. Nanjo, N. Katakami, R. Tachikawa, A. Hata, R. Kaji, S. Fujita, M. Hayashi, K. Tomii (Kobe, Japan)
| |
Retrospective assessment of non small cell lung cancer stage IIIA-IIIB, treated with neoadjuvant chemotherapy
A. Caprioli, E. Roca, D. Modina, G. Bozzola, A. M. Nava, G. Tassi (Brescia, Italy)
| |
Surgical treatment of synchronous adrenal metastasis from NSCLC is beneficial or not
K. Kavakli, H. Caylak, H. Isik, O. Yucel, E. Sapmaz, S. Cubuk, S. Gurkok, O. Genc, S. Aydin (Ankara, Turkey)
| |
Survival of patients after complete surgical resection in NSCLC stage IV with solitary metastases
M. Tönnies, D. Misch, J. Kollmeier, T. Bauer, D. Kaiser (Berlin, Germany)
| |
Combined and organ-saving operations in patients with advanced lung cancer after induction chemotherapy
O. Sukhoversha (Dnipropetrovsk, Ukraine)
| |
Trimodality treatment in patients with superior sulcus tumors
Z. Kocak, M. Saynak, G. Altiay, A. Ozen, N. Sut, Y. Yoruk (Edirne, Turkey)
| |
Factors affecting the prognosis of nonsmall cell lung cancer with chest wall-parietal pleural invasion (T3) following resection
S. Anar, C. Anar, A. Üçvet, S. Gürsoy, S. Örs Kaya (Izmir, Turkey)
| |
A 10-year experience of pleurodesis for malignant pleural effusion in a district general hospital
A. Al-Ameri, J. Stowell, S. Lok (Welwyn Garden City, United Kingdom)
| |
The efficacy and safety of stereotactic radiation therapy for elderly patients
K. Ando, K. Shoji, M. Fukazawa, A. Takeshi, Y. Ohkuni, N. Kaneko (Kamogawa, Japan)
| |
Whole brain re-irradiation in lung cancer patients with multiple brain metastases
N. Jovanovic Korda, S. Vucicevic, G. Gligorijevic (Beograde, Belgrade, Republic Of Serbia)
| |
Symptomatic benefit of short regimen of palliative radiotherapy for elderly patients with locally advanced non small cell lung cancer
N. Jovanovic Korda, S. Vucicevic, G. Gligorijevic (Belgrade, Republic Of Serbia)
| |